| Primary |
| Nail Tinea |
31.4% |
| Onychomycosis |
29.1% |
| Tinea Pedis |
8.6% |
| Fungal Infection |
5.8% |
| Hypertension |
5.7% |
| Tinea Infection |
2.3% |
| Depression |
2.2% |
| Constipation |
1.6% |
| Diabetes Mellitus |
1.6% |
| Insomnia |
1.5% |
| Hyperlipidaemia |
1.4% |
| Fungal Skin Infection |
1.3% |
| Seborrhoeic Dermatitis |
1.3% |
| Parkinson's Disease |
1.0% |
| Epilepsy |
1.0% |
| Eczema |
0.9% |
| Nail Infection |
0.9% |
| Gastritis |
0.8% |
| Asthma |
0.8% |
| Cerebral Infarction |
0.7% |
|
| Rhabdomyolysis |
12.2% |
| Weight Decreased |
12.2% |
| White Blood Cell Count Decreased |
7.8% |
| Urticaria |
7.5% |
| White Blood Cell Count Increased |
6.7% |
| Blood Creatine Phosphokinase Increased |
6.3% |
| Pyrexia |
6.3% |
| Rash |
5.0% |
| Liver Disorder |
4.4% |
| Pruritus |
3.8% |
| Skin Exfoliation |
3.8% |
| Vomiting |
3.7% |
| Ageusia |
2.9% |
| Drug Exposure During Pregnancy |
2.9% |
| Tremor |
2.8% |
| Drug Ineffective |
2.6% |
| Platelet Count Decreased |
2.5% |
| Hypoaesthesia |
2.2% |
| Myalgia |
2.2% |
| Toxic Skin Eruption |
2.2% |
|
| Secondary |
| Drug Use For Unknown Indication |
20.6% |
| Onychomycosis |
18.1% |
| Hypertension |
7.8% |
| Nail Tinea |
7.1% |
| Tinea Pedis |
6.5% |
| Fungal Infection |
6.0% |
| Diabetes Mellitus |
4.0% |
| Pruritus |
3.9% |
| Product Used For Unknown Indication |
2.9% |
| Rash |
2.9% |
| Osteitis |
2.5% |
| Fungal Skin Infection |
2.4% |
| Blood Cholesterol Increased |
2.2% |
| Parkinson's Disease |
2.2% |
| Systemic Mycosis |
2.2% |
| Tinea Infection |
2.2% |
| Depression |
1.7% |
| Multiple Sclerosis |
1.7% |
| Psoriatic Arthropathy |
1.7% |
| Insomnia |
1.5% |
|
| Rhabdomyolysis |
9.0% |
| Toxic Skin Eruption |
8.2% |
| Hepatic Function Abnormal |
6.7% |
| Platelet Count Decreased |
6.7% |
| Vasculitis |
5.2% |
| Visual Acuity Reduced |
5.2% |
| Weight Increased |
5.2% |
| White Blood Cell Count Decreased |
5.2% |
| Medication Error |
4.5% |
| Rash |
4.5% |
| Suicidal Ideation |
4.5% |
| Syncope |
4.5% |
| Therapeutic Response Unexpected |
4.5% |
| Tremor |
4.5% |
| Blood Creatine Phosphokinase Increased |
3.7% |
| Myocardial Infarction |
3.7% |
| Pyrexia |
3.7% |
| Swelling |
3.7% |
| Thrombocytopenia |
3.7% |
| Drug Dispensing Error |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.9% |
| Drug Use For Unknown Indication |
10.7% |
| Hypertension |
7.6% |
| Rheumatoid Arthritis |
6.7% |
| Depression |
4.9% |
| Insomnia |
4.3% |
| Diabetes Mellitus |
3.6% |
| Prophylaxis |
3.6% |
| Rash |
3.6% |
| Constipation |
3.4% |
| Pain |
3.4% |
| Onychomycosis |
3.2% |
| Hiv Infection |
2.7% |
| Tinea Pedis |
2.6% |
| Psoriasis |
2.5% |
| Tinea Infection |
2.3% |
| Rhinitis Allergic |
2.1% |
| Fungal Infection |
2.0% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Osteoporosis |
2.0% |
|
| Weight Decreased |
10.5% |
| Type 2 Diabetes Mellitus |
9.6% |
| Weight Increased |
9.6% |
| Tremor |
8.7% |
| Pyrexia |
6.1% |
| Vomiting |
5.2% |
| Hepatic Function Abnormal |
4.8% |
| Pain In Extremity |
4.8% |
| Subileus |
4.8% |
| Urticaria |
4.8% |
| Death |
3.5% |
| Pulmonary Embolism |
3.5% |
| Drug Ineffective |
3.1% |
| Femur Fracture |
3.1% |
| Incorrect Dose Administered |
3.1% |
| Insomnia |
3.1% |
| Myocardial Infarction |
3.1% |
| Pruritus |
3.1% |
| Suicidal Ideation |
3.1% |
| Mental Disorder |
2.6% |
|
| Interacting |
| Product Used For Unknown Indication |
11.8% |
| Fungal Infection |
8.8% |
| Onychomycosis |
8.8% |
| Aggression |
5.9% |
| Bipolar Disorder |
5.9% |
| Hypertension |
5.9% |
| Influenza |
5.9% |
| Nasopharyngitis |
5.9% |
| Pyrexia |
5.9% |
| Skin Disorder |
5.9% |
| Anxiety |
2.9% |
| Arteriosclerosis |
2.9% |
| Dementia Alzheimer's Type |
2.9% |
| Diabetes Mellitus |
2.9% |
| Dyslipidaemia |
2.9% |
| Hallucination |
2.9% |
| Hypercholesterolaemia |
2.9% |
| Ill-defined Disorder |
2.9% |
| Insomnia |
2.9% |
| Nail Infection |
2.9% |
|
| Drug Interaction |
33.3% |
| Nephrosclerosis |
16.7% |
| Depression |
8.3% |
| Fungal Skin Infection |
8.3% |
| Incorrect Dose Administered |
8.3% |
| Overdose |
8.3% |
| Rash |
8.3% |
| Skin Laceration |
8.3% |
|
